These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1467455)

  • 1. Sex-differences in the disposition of substituted benzamides: pharmacokinetics of a gastroprokinetic agent (4-amino-5-chloro-2-[2- (methylsulfinyl) ethoxy]-N-[2-(diethylamino)ethyl] benzamide hydrochloride) (ML-1035) in male and female New Zealand white rabbits.
    Rao N; Otis KW; Hwang KK
    Biopharm Drug Dispos; 1992 Dec; 13(9):681-91. PubMed ID: 1467455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolic interconversion of intravenous 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2-(diethylamino)ethyl] benzamide and its sulfide and sulfone metabolites in rats.
    Kuo BS; Poole JC; Hwang KK; Cheng H
    J Pharm Sci; 1993 Jul; 82(7):694-8. PubMed ID: 8360842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bioavailability and systemically available fractions of drugs undergoing reversible metabolism: application to 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethylamino)ethyl]benzamide and its sulfide and sulfone metabolites in rats.
    Kuo BS; Poole JC; Hwang KK; Cheng H
    J Pharm Sci; 1994 Mar; 83(3):386-90. PubMed ID: 8207687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition kinetics of ML-1035 sulfoxide enantiomers and the prochiral sulfide in rats.
    Kuo BS; Poole JC; Mandagere AK; Hwang KK
    Chirality; 1993; 5(6):428-35. PubMed ID: 8398602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of the anti-emetic agent bromopride.
    Brodie RR; Chasseaud LF; Darragh A; Lambe RF; Rooney L; Taylor T
    Biopharm Drug Dispos; 1986; 7(3):215-22. PubMed ID: 3730521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in rats.
    Sakashita M; Mizuki Y; Hashizume T; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):859-63. PubMed ID: 8216443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resolution, isolation, and pharmacological characterization of the enantiomers of a benzamide containing a chiral sulfoxide.
    Butler BT; Silvey G; Houston DM; Borcherding DR; Vaughn VL; McPhail AT; Radzik DM; Wynberg H; ten Hoeve W; van Echten E
    Chirality; 1992; 4(3):155-62. PubMed ID: 1586586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
    Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits.
    Abd El-Aty AM; Goudah A; Abo El-Sooud K; El-Zorba HY; Shimoda M; Zhou HH
    Vet Res Commun; 2004 Aug; 28(6):515-24. PubMed ID: 15509025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodisposition of thiamphenicol in rabbits.
    Abd El-Aty AM; Abo El Sooud K; Goudah AM
    Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and pharmacokinetics of metoclopramide in cattle.
    Jones RD; Mizinga KM; Thompson FN; Stuedemann JA; Bowen JM
    J Vet Pharmacol Ther; 1994 Apr; 17(2):141-7. PubMed ID: 8040934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and disposition of metoclopramide after single- and multiple-dose administration in diabetic patients with gastroparesis.
    O'Connell ME; Awni WM; Goodman M; Cass O; Melikian AP; Wright GJ; Matzke GR
    J Clin Pharmacol; 1987 Aug; 27(8):610-4. PubMed ID: 3655009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate.
    Chen CL; Sangiah S; Roder JD; Chen H; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R
    Arzneimittelforschung; 1995 Jun; 45(6):670-5. PubMed ID: 7646568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.